COVID-19
Conditions
Keywords
vaccine confidence
Brief summary
The ENSPIRE study is a cluster-randomized comparative effectiveness trial being conducted within long-term care and residential facilities that will test a communication and engagement strategy for increasing COVID-19 booster vaccination rates against an enhanced usual care comparator (Centers for Disease Control and Prevention or other national organization vaccine education and communication materials) among facility staff. The communication and engagement strategy being tested includes (1) the development of materials co-designed with and tailored to facility staff whose primary language is a language other than English or who are from certain cultural affinity groups and (2) the distribution of the developed materials by members of the language/cultural affinity groups with peer advocacy activities (full intervention). The study is being conducted in Washington state and Georgia. Long-term care/residential facilities will be asked to furnish their staff booster rate at 4 timepoints: pre-intervention, and one month (timepoint 1), 3 months (timepoint 2), and 6 months (timepoint 3) post-intervention. Staff at participating long-term care facilities will be invited to complete three online surveys at 3 timepoints: pre-intervention, 3 months post-intervention and 6 months post-intervention. Long-term care facilities will be randomized to a trial arm following the pre-intervention data collection.
Interventions
BEHAVIORALFull Intervention
A small group of employees who work at facilities randomized to this arm will be invited to develop tailored COVID-19 vaccination promotion materials in teams with other long-term care staff sharing the same or similar language and/or cultural affinity. These employees will also help promote these materials to all of the employees who work at their facilities.
OTHEREnhanced Usual Care
Employees who work at facilities randomized to this arm will see COVID-19 vaccine promotion materials from the Centers for Disease Control and Prevention \[CDC\] or other national organization.
Sponsors
Patient-Centered Outcomes Research Institute
Global Alliance to Prevent Prematurity and Stillbirth (GAPPS)
Kaiser Permanente
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Works at a participating long-term care facility that has more than 50 staff members, has a staff COVID-19 booster vaccination rate of ≤60% as of December 1, 2021, and is located in Washington state or Georgia. * 18 years or older
Exclusion criteria
* Does not work at an enrolled long-term care facility * 17 years or younger
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in COVID-19 booster vaccination rate | Baseline (Time 0); 7 months post-randomization (Time 1); 10 months post-randomization (Time 2); 13 months post-randomization (Time 3) | Change in percentage of staff at long-term care centers that have received a booster vaccine over time. |
| Change in likelihood of recommending COVID-19 vaccination | Baseline (Time 0); 10 months post-randomization (Time 2); 13 months post-randomization (Time 3) | Change in likelihood of recommending COVID-19 vaccination to others (coworkers, family, friends) assessed using a 6-item Net Promoter Score scale. The scale is assessed on an 11-point scale ranging from 0 ('Least Likely') to 10 ('Most Likely'). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in vaccine hesitancy | Baseline (Time 0); 10 months post-randomization (Time 2); 13 months post-randomization (Time 3) | Change in vaccine hesitancy assessed using a modified Vaccine Hesitancy Scale with 11 items. The scale is assessed on a 5-point Likert scale with answer choices ranging from 'Strongly Disagree' to 'Strongly Agree.' |
| Change in COVID-19 vaccine confidence | Baseline (Time 0); 10 months post-randomization (Time 2); 13 months post-randomization (Time 3) | Change in vaccine confidence using a modified 3-item Vaccine Confidence Scale. The answer choices are on a Likert-scale: 'strongly agree', 'tend to agree', 'tend to disagree', 'strongly disagree', and 'I don't know.' |
Other
| Measure | Time frame | Description |
|---|---|---|
| Change in COVID-19 vaccine knowledge | Baseline (Time 0); 10 months post-randomization (Time 2); 13 months post-randomization (Time 3) | Change in COVID-19 vaccine knowledge using 6 COVID-19 vaccine knowledge true/false questions adapted from information on the CDC's COVID-19 Myths and Facts webpage. |
| Change in COVID-19 vaccine attitudes | Baseline (Time 0); 10 months post-randomization (Time 2); 13 months post-randomization (Time 3) | Change in COVID-19 vaccine attitudes using 10 questions assessed on a 5-point Likert scale adapted from existing surveys and polls assessing COVID-19 vaccine perceptions. |
Countries
United States
Outcome results
None listed